Search for Clinical Trial Results

Sponsored By

Hemangiosarcoma - 25 Studies Found

Status Study
Recruiting Study Name: A RANDOMIZED PHASE 3 TRIAL OF TRC105 AND PAZOPANIB VERSUS PAZOPANIB ALONE IN PATIENTS WITH ADVANCED ANGIOSARCOMA
Condition: Advanced Angiosarcoma
Date: 2016-11-29
Interventions:
  • Biological: TRC105 Other Names
Active, not recruiting Study Name: Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas
Condition: Angiosarcoma
Date: 2011-02-23
Interventions:
  • Drug: Paclitaxel Day 1, 8 and

Not yet recruiting Study Name: Cytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic Correlation
Condition: Hepatic Angiosarcoma
Date: 2017-01-16
Recruiting Study Name: Evaluation of Votrient in Angiosarcoma
Condition: Angiosarcoma
Date: 2014-07-29
Interventions: Drug: Pazopanib + Paclitaxel pazopanib in combination with paclitaxel in the treatment of patients with
Active, not recruiting Study Name: Identification, Molecular Epidemiology Angiosarcoma of the Liver France
Condition: Angiosarcoma
Date: 2013-02-06
Interventions:
  • Biological: blood and urine Bl
Active, not recruiting Study Name: Paclitaxel + Bevacizumab (Avastin®) for the Treatment of Metastatic or Unresectable Angiosarcoma
Condition:
  • Angiosarcomas
  • Soft Tissue Sarcoma

Date: 2010-01-21
Interventions: Drug: Paclitaxel in combination with Bevacizumab 15 mg/kg, IV
Not yet recruiting Study Name: Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO)
Condition: Angiosarcoma
Date: 2016-03-29
Interventions: Drug: PROPRANOLOL
Recruiting Study Name: Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma
Condition:
  • Adult Angiosarcoma
  • Recurrent Adult Soft Tissue Sarcoma
    • Date: 2011-10-27
    Interventions:
    • Drug: pazopanib hydrochloride

Completed Study Name: Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery
Condition:
  • Adult Angiosarcoma
  • Recurrent Adult Soft Tissue Sarcoma
    • Date: 2012-06-17
    Interventions:
    • Other: Laboratory Biomarker Analysis

Recruiting Study Name: Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma
Condition:
  • Adult Angiosarcoma
  • Recurrent Adult Soft Tissue Sarcoma
    • Date: 2014-01-22
    Interventions: Drug: regorafenib Given PO Other Names:
Next >>>